Dimopoulos, M. A., Oriol, A., Nahi, H., San-Miguel, J., Bahlis, N. J., Usmani, S. Z., Rabin, N., Orlowski, R. Z., Suzuki, K., Plesner, T., Yoon, S., Ben Yehuda, D., Richardson, P. G., Goldschmidt, H., Reece, D., Ahmadi, T., Qin, X., Garvin Mayo, W., Gai, X., Carey, J., Carson, R., & Moreau, P. (2023). overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial. Journal of clinical oncology, 41(8), 1590–1599. http://access.bl.uk/ark:/81055/vdc_100183022054.0x000020